-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Neutral on Fulgent Genetics, Raises Price Target to $25

Benzinga·11/10/2026 12:54:51
Listen to the news
Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and raises the price target from $19 to $25.